BioMatrix Specialty Pharmacy, a nationwide specialty pharmacy provider, announced yesterday that it has named Nick Karalis as its new chief executive officer.
Presently, Karalis serves as BioMatrix chief operating officer and will also serve on the firm's board of directors.
Karalis is a graduate of University of the Sciences and has more than 25 years of executive leadership experience as a pharmacist and pharmacy owner/operator. He was a founding principal and CEO of Elwyn Pharmacy Group, which became part of BioMatrix in 2017. He was also a co-founder and president at Community Specialty Pharmacy Network. His prior experience includes various pharmacy companies that he founded and operated. He is a member of Cardinal Health's National Advisory Board and on the Leadership Counsel for the American Red Cross. He is a founding board member of Hellenic Hearts, an editorial board member of Specialty Pharmacy Times and the winner of the 2014 Smart/CEO Circle of Excellence award.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business